ConductScience.org, home

Paper40575656

Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin.

Yan Y and 6 others. Mater Today Bio, 2025. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin. Papers, record 40575656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40575656

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin.
PubMed
Journal
Mater Today Bio
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
14.99, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yan YYuxing
2Kulsoom
3Sun YYanbo
4Li YYingjie
5Wang ZZhenlong
6Xue LLi
7Wang FFu

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References211

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122927762Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells.Int J Nanomedicine2012https://conductscience.org/library/papers/22927762PubMed
239941855Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations.Cancers (Basel)2025https://conductscience.org/library/papers/39941855PubMed
339591076Improvement in Curcumin's Stability and Release by Formulation in Flexible Nano-Liposomes.Nanomaterials (Basel)2024https://conductscience.org/library/papers/39591076PubMed
422609787Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics.Molecules2012https://conductscience.org/library/papers/22609787PubMed
525749519NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10.Oncotarget2015https://conductscience.org/library/papers/25749519PubMed
629751694Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes.Molecules2018https://conductscience.org/library/papers/29751694PubMed
736144994The Potential of Curcumin-Capped Nanoparticle Synthesis in Cancer Therapy: A Green Synthesis Approach.Nanomaterials (Basel)2022https://conductscience.org/library/papers/36144994PubMed
817341611Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution.Ann N Y Acad Sci2006https://conductscience.org/library/papers/17341611PubMed
933405725Bioinspired Polymerization of Quercetin to Produce a Curcumin-Loaded Nanomedicine with Potent Cytotoxicity and Cancer-Targeting Potential in Vivo.ACS Biomater Sci Eng2019https://conductscience.org/library/papers/33405725PubMed
1033496383Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line.Environ Toxicol2021https://conductscience.org/library/papers/33496383PubMed
1112473670
Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways.
J Biol Chem2003https://conductscience.org/library/papers/12473670PubMed
1236152892Ferritin nanocage based delivery vehicles: From single-, co- to compartmentalized- encapsulation of bioactive or nutraceutical compounds.Biotechnol Adv2022https://conductscience.org/library/papers/36152892PubMed
1339943855Nanoencapsulation enhanced the performance of β-carotene for ameliorating inflammation in patient-derived organoids.Nanomedicine (Lond)2025https://conductscience.org/library/papers/39943855PubMed
1437492509Curcumin-loaded mesoporous silica nanoparticles for drug delivery: synthesis, biological assays and therapeutic potential - a review.RSC Adv2023https://conductscience.org/library/papers/37492509PubMed
1529025645Enhancing the anti-gastric cancer activity of curcumin with biocompatible and pH sensitive PMMA-AA/ZnO nanoparticles.Mater Sci Eng C Mater Biol Appl2018https://conductscience.org/library/papers/29025645PubMed
1637504415Dual pH- and Thermo-Sensitive Poly(N-isopropylacrylamide-co-allylamine) Nanogels for Curcumin Delivery: Swelling-Deswelling Behavior and Phase Transition Mechanism.Gels2023https://conductscience.org/library/papers/37504415PubMed
1730669284Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells.Int J Mol Sci2019https://conductscience.org/library/papers/30669284PubMed
1814500688Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells.J Immunol2003https://conductscience.org/library/papers/14500688PubMed
197559628Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected].J Biol Chem1995https://conductscience.org/library/papers/7559628PubMed
2017555831Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity.Biochim Biophys Acta2007https://conductscience.org/library/papers/17555831PubMed

See all 211 referencesDownload CSV of references

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
42974146Curcumin pharmacology and pharmacokinetics: current challenges and future perspectives in nanoemulsion delivery.Beilstein J Nanotechnol2026https://conductscience.org/library/papers/42974146PubMed
42930824Electrospun Nanofiber Therapeutics for Localized Post-Surgical Breast Cancer Treatment.J Funct Biomater2026https://conductscience.org/library/papers/42930824PubMed
42893963CDK4/6 Inhibitors and Curcumin Synergistically Suppress HER2- Breast Cancer via Lethal ROS and Inhibition of Metastasis.Cancer Sci2026https://conductscience.org/library/papers/42893963PubMed
42830956Macrophage-Based Nanoplatforms for Tumor-Targeted Drug Delivery and Cancer Immunomodulation: Extracellular Vesicles, Membrane-Coated Nanoparticles, and Live Cells.Int J Nanomedicine2026https://conductscience.org/library/papers/42830956PubMed
42699515Plant polyphenols as context-dependent modulators of cellular signalling networks.Front Nutr2026https://conductscience.org/library/papers/42699515PubMed
42683198Natural Medicines Modulating Tumor Perineural Invasion: Regulatory Mechanisms and Therapeutic Potential.Drug Des Devel Ther2026https://conductscience.org/library/papers/42683198PubMed
42645768Curcumin-loaded PEGylated Magnetic Iron Oxide Nanoparticles: a Biogenic Platform for Targeted and Controlled Drug Release.Appl Biochem Biotechnol2026https://conductscience.org/library/papers/42645768PubMed
42539521Curcumin Attenuates Breast Cancer Cell-induced Inflammasome Activation via the NOD-like receptor protein 3/Caspase-1/Interleukin-1β Axis.J Cancer Prev2026https://conductscience.org/library/papers/42539521PubMed
42464296Advanced herbal self-assembled nanoplatforms: targeted, stimuli-responsive, and precision therapeutics for human diseases.J Nanobiotechnology2026https://conductscience.org/library/papers/42464296PubMed
42376460The emerging role of oncolytic virotherapy in genitourinary malignancies.Front Cell Dev Biol2026https://conductscience.org/library/papers/42376460PubMed
42370350Curcumin as theranostics: imaging-guided therapeutics in oncology and neurodegenerative diseases.Front Nutr2026https://conductscience.org/library/papers/42370350PubMed
42351108A magnetic resonance imaging-guided drug delivery system for premetastatic niche theranostics and colorectal cancer liver metastasis intervention.J Nanobiotechnology2026https://conductscience.org/library/papers/42351108PubMed
42311420Intranasal Delivery of Curcumin-Loaded Pure Drug Self-Assembled Lipid-Based Nanoparticles for Targeted Therapy of Depression.Int J Nanomedicine2026https://conductscience.org/library/papers/42311420PubMed
42243927Histone modifications across cancers: mechanisms, therapy and clinical translation.Mol Cancer2026https://conductscience.org/library/papers/42243927PubMed
42176148Nature meets immunity: curcumin's role in modulating neutrophil extracellular traps.Inflammopharmacology2026https://conductscience.org/library/papers/42176148PubMed
42137470A QbD-optimized magnetic MOF-chitosan nanocarrier for targeted curcumin delivery and synergistic antimicrobial activity.RSC Adv2026https://conductscience.org/library/papers/42137470PubMed
42088575The oxidative stress-inflammation self-perpetuating cycle in multiple sclerosis: from mechanisms to emerging antioxidant strategies.Front Pharmacol2026https://conductscience.org/library/papers/42088575PubMed
42075010Turmeric: A Comprehensive Review of Its Botany, Traditional Uses, Phytochemistry, and Mechanisms as a Functional Food.Nutrients2026https://conductscience.org/library/papers/42075010PubMed
42038028Targeting MUC16 to Reverse Anoikis Resistance: A Promising Strategy for Metastatic Lung Adenocarcinoma Therapy.J Cancer2026https://conductscience.org/library/papers/42038028PubMed
41823875Curcumin Enhances Gemcitabine Sensitivity in Breast Cancer Cells Through ROS-Associated Mitochondrial Apoptosis and Transcriptional Reprogramming.Biology (Basel)2026https://conductscience.org/library/papers/41823875PubMed

See all 41 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40575656

GET https://conductscience.org/api/papers/v1/40575656/references?page=2